封面
市場調查報告書
商品編碼
1428006

2024 年短讀定序全球市場報告

Short Read Sequencing Global Market Report 2024

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

短讀長定序的市場規模預計在未來幾年將快速成長。預計到 2028 年將以 17.4% 的複合年成長率 (CAGR) 成長至 129.7 億美元。預測期內的預期成長可歸因於精準醫學的進步、個人化基因組學的快速擴張、農業應用的增加、微生物組研究的激增以及新興市場需求的增加。預測期內預計的主要趨勢包括自動化和高通量技術、雲端基礎的解決方案的採用、人工智慧和機器學習的整合、可攜式定序技術的發展、長讀長定序的協同效應等將出現。

遺傳疾病盛行率的預期增加預計將在可預見的未來推動短讀定序市場的成長。遺傳性疾病是由個體 DNA 或基因的異常或突變引起的,導致身體、發育或生化異常,進而影響健康。短讀長定序可以幫助基因組分析,以全面識別與疾病相關的變異。例如,2022 年 6 月的 RARE-X 報告總合揭示了 10,867 種罕見疾病,包括遺傳性疾病和非遺傳性疾病。因此,遺傳疾病的流行是短讀長定序市場擴大的關鍵驅動力。

個人化醫療的日益普及極大地促進了短讀長定序市場的預期成長。個人化醫療根據個人獨特的基因組成客製化醫療護理,提供更有效、更精準的醫療干預措施。短讀長定序在識別影響藥物反應的遺傳變異、促進個人化治療計畫的發展方面發揮關鍵作用。例如,根據美國個人化醫療聯盟的資料,2022 年食品藥物管理局藥物評估與研究中心核准的37 個新分子實體中,約 34%(即 12 個)被歸類為個人化醫療。2023年1月。顯示為機密。因此,個人化醫療的日益普及必將推動短讀定序市場。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長,2023-2028、2033

第6章市場區隔

  • 全球短讀定序市場,依產品細分,實際與預測,2018-2023、2023-2028、2033
  • 裝置
  • 消耗品
  • 服務
  • 全球短讀定序市場,依設備細分,實際與預測,2018-2023、2023-2028、2033
  • 下一代定序
  • Sanger序列測定
  • 全球短讀定序市場,依工作流程細分,實際與預測,2018-2023、2023-2028、2033
  • 預測定序
  • 定序
  • 資料分析
  • 全球短讀定序市場,依應用細分、實際與預測,2018-2023、2023-2028、2033
  • 臨床調查
  • 腫瘤學
  • 生殖健康
  • 消費者基因體學
  • 農業基因組學與法醫學
  • HLA型檢測/免疫系統監測
  • 全球短讀定序市場,依最終用戶細分,實際與預測,2018-2023、2023-2028、2033
  • 學術研究
  • 醫院和診所
  • 臨床調查
  • 製藥和生物技術公司

第 7 章 區域與國家分析

  • 全球短讀定序市場(按地區、實際情況和預測),2018-2023、2023-2028、2033
  • 全球短讀定序市場,依國家、實際及預測,2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 短讀長定序市場競爭形勢
  • 短讀定序市場公司概況
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • GE HealthCare Technologies Inc.
    • Cytiva Lifesciences
    • Eurofins Scientific SE

第31章 其他大型創新公司

  • Agilent Technologies Inc.
  • Beckman Coulter Inc.
  • Illumina Inc.
  • QIAGEN NV
  • PerkinElmer Inc.
  • BGI Genomics Co Ltd
  • MGI Tech Co. Ltd.
  • GenScript Biotech Corporation.
  • 10x Genomics Inc.
  • Novogene Co. Ltd
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California Inc.
  • Macrogen Inc.
  • Genewiz Inc.
  • Zymo Research Corporation

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r13850

Short-read sequencing, also known as next-generation sequencing (NGS), is a high-throughput DNA sequencing technique that produces short fragments or reads of DNA sequences. It has revolutionized genomics by facilitating the rapid and cost-effective analysis of entire genomes and transcriptomes.

The primary product categories in short-read sequencing comprise instruments, consumables, and services. Short-read sequencing instruments are the platforms or machines employed to generate short DNA fragments for analysis, allowing for the identification of genetic variations, mutations, and gene expression levels. Various technologies, including next-generation sequencing and Sanger sequencing, are utilized in workflows such as pre-sequencing, sequencing, and data analysis. These applications find use in clinical investigation, oncology, reproductive health, consumer genomics, agri genomics, forensics, HLA typing, and immune system monitoring. End users of short-read sequencing encompass academic research, hospitals and clinics, clinical research, and pharmaceutical and biotechnology companies.

The short-read sequencing market research report is one of a series of new reports from The Business Research Company that provides short-read sequencing statistics, including short-read sequencing industry global market size, regional shares, competitors with a short-read sequencing market share, detailed short-read sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the short-read sequencing industry. This short-read sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The short read sequencing market size has grown rapidly in recent years. It will grow from $5.74 billion in 2023 to $6.82 billion in 2024 at a compound annual growth rate (CAGR) of 18.9%. The growth observed in the historical period can be attributed to initiatives in genomic research, a higher prevalence of genetic disorders, research activities in the pharmaceutical and biotechnology sectors, applications in diagnostics, and the decreasing costs associated with sequencing.

The short read sequencing market size is expected to see rapid growth in the next few years. It will grow to $12.97 billion in 2028 at a compound annual growth rate (CAGR) of 17.4%. The projected growth in the forecast period can be attributed to advancements in precision medicine, the rapid expansion of personalized genomics, increasing applications in agriculture, a surge in microbiome research, and a rising demand in emerging markets. Key trends anticipated in the forecast period encompass automation and high-throughput technologies, the adoption of cloud-based solutions, integration of AI and machine learning, the development of portable sequencing technologies, and the synergy of long-read sequencing.

The anticipated increase in the prevalence of genetic diseases is set to drive the growth of the short-read sequencing market in the foreseeable future. Genetic diseases arise from abnormalities or mutations in an individual's DNA or genes, leading to physical, developmental, or biochemical irregularities that can impact their health. Short-read sequencing is instrumental in the analysis of genomes for identifying disease-associated variants comprehensively. For instance, a report by RARE-X in June 2022 highlighted a total of 10,867 rare diseases, encompassing both genetic and non-genetic conditions. Therefore, the growing prevalence of genetic diseases is a key driver behind the expansion of the short-read sequencing market.

The increasing adoption of personalized medicine is a significant contributor to the anticipated growth of the short-read sequencing market. Personalized medicine customizes medical treatment based on an individual's unique genetic makeup, providing more effective and precise healthcare interventions. Short-read sequencing plays a pivotal role in identifying genetic variations influencing drug response, facilitating the development of personalized treatment plans. For example, data from the Personalized Medicine Coalition in January 2023 indicated that out of the 37 new molecular entities approved by the Food and Drug Administration's Center for Drug Evaluation and Research in 2022, approximately 34%, or 12 of them, are classified as personalized medicines. Hence, the increasing adoption of personalized medicine is poised to drive the short-read sequencing market.

Technological advancements emerge as a key trend gaining momentum in the short-read sequencing market. Major companies in this market are focusing on technological advancements to enhance observation capabilities and maintain their positions. In October 2022, Pacific Biosciences Inc., a US-based producer of highly accurate sequencing technologies, initiated external beta testing of the Onso sequencing system. This system was designed to offer precise data while remaining cost-effective, catering to the needs of oncology researchers for sensitive and specific targeted sequence analysis findings.

Major companies operating in the short-read sequencing market are concentrating on the development of cost-effective short-read sequencers, specifically production-scale sequencers, to efficiently serve their users. Production-scale sequencers are high-throughput DNA sequencing platforms designed for large-scale genomic analysis in fields such as genomics, agriculture, and clinical research. For instance, Illumina, a US-based biotechnology company, launched the NovaSeq X Series in October 2022. This new technology, comprising NovaSeq X and NovaSeq X Plus, features production-scale sequencers designed to advance genomic medicine, providing faster, more powerful, and sustainable sequencing. The NovaSeq X Plus, capable of sequencing over 20,000 whole genomes per year, accelerates genomic discovery and clinical insights, while also demonstrating Illumina's commitment to reducing waste and environmental impact.

In September 2021, Pacific Biosciences of California, Inc., a US-based biotechnology company, acquired Omniome Inc. for $800 million. This strategic acquisition enhances Pacific Biosciences' portfolio by positioning the company as the sole provider of highly accurate long-read and short-read sequencing technologies. Omniome Inc. is a US-based biotechnology company specializing in highly accurate native long-read and short-read sequencing platforms.

Major companies operating in the short read sequencing market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE HealthCare Technologies Inc., Cytiva Lifesciences, Eurofins Scientific SE, Agilent Technologies Inc., Beckman Coulter Inc., Illumina Inc., QIAGEN N.V., PerkinElmer Inc., BGI Genomics Co Ltd., MGI Tech Co. Ltd., GenScript Biotech Corporation., 10x Genomics Inc., Novogene Co. Ltd., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., Genewiz Inc., Zymo Research Corporation, GenapSys Inc., Fasteris SA, GnuBIO Inc., Paragon Genomics Inc., Nabsys Inc., GATC Biotech AG, Halcyon Molecular Inc.

North America was the largest region in the Short Read Sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short read sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the short read sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The short-read sequencing market includes revenues earned by entities by providing short-read sequencing services such as sequencing services, bioinformatics, sample processing, sequencing runs, data generation, and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The short-read sequencing market also consists of sales-related products such as sequencing instruments, reagents, and consumables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Short Read Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on short read sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for short read sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The short read sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Instruments; Consumables; Services.
  • 2) By Technology: Next-Generation Sequencing; Sanger Sequencing.
  • 3) By Workflow: Pre-Sequencing; Sequencing; Data Analysis.
  • 4) By Application: Clinical Investigation; Oncology; Reproductive Health; Consumer Genomics; Agri genomics and Forensics; HLA Typing/ Immune System Monitoring.
  • 5) By End Users: Academic Research; Hospitals and Clinics; Clinical Research; Pharmaceutical and Biotechnology Companies.
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; GE HealthCare Technologies Inc.; Cytiva Lifesciences; Eurofins Scientific SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Short-Read Sequencing Market Characteristics

3. Short-Read Sequencing Market Trends And Strategies

4. Short-Read Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Short-Read Sequencing Market Size and Growth

  • 5.1. Global Short-Read Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Short-Read Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Short-Read Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Short-Read Sequencing Market Segmentation

  • 6.1. Global Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments
  • Consumables
  • Services
  • 6.2. Global Short-Read Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Next-Generation Sequencing
  • Sanger Sequencing
  • 6.3. Global Short-Read Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pre-Sequencing
  • Sequencing
  • Data Analysis
  • 6.4. Global Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Clinical Investigation
  • Oncology
  • Reproductive Health
  • Consumer Genomics
  • Agri genomics and Forensics
  • HLA Typing/ Immune System Monitoring
  • 6.5. Global Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic Research
  • Hospital and Clinics
  • Clinical Research
  • Pharmaceutical and Biotechnology Companies

7. Short-Read Sequencing Market Regional And Country Analysis

  • 7.1. Global Short-Read Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Short-Read Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Short-Read Sequencing Market

  • 8.1. Asia-Pacific Short-Read Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Short-Read Sequencing Market

  • 9.1. China Short-Read Sequencing Market Overview
  • 9.2. China Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Short-Read Sequencing Market

  • 10.1. India Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Short-Read Sequencing Market

  • 11.1. Japan Short-Read Sequencing Market Overview
  • 11.2. Japan Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Short-Read Sequencing Market

  • 12.1. Australia Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Short-Read Sequencing Market

  • 13.1. Indonesia Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Short-Read Sequencing Market

  • 14.1. South Korea Short-Read Sequencing Market Overview
  • 14.2. South Korea Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Short-Read Sequencing Market

  • 15.1. Western Europe Short-Read Sequencing Market Overview
  • 15.2. Western Europe Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Short-Read Sequencing Market

  • 16.1. UK Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Short-Read Sequencing Market

  • 17.1. Germany Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Short-Read Sequencing Market

  • 18.1. France Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Short-Read Sequencing Market

  • 19.1. Italy Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Short-Read Sequencing Market

  • 20.1. Spain Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Short-Read Sequencing Market

  • 21.1. Eastern Europe Short-Read Sequencing Market Overview
  • 21.2. Eastern Europe Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Short-Read Sequencing Market

  • 22.1. Russia Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Short-Read Sequencing Market

  • 23.1. North America Short-Read Sequencing Market Overview
  • 23.2. North America Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Short-Read Sequencing Market

  • 24.1. USA Short-Read Sequencing Market Overview
  • 24.2. USA Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Short-Read Sequencing Market

  • 25.1. Canada Short-Read Sequencing Market Overview
  • 25.2. Canada Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Short-Read Sequencing Market

  • 26.1. South America Short-Read Sequencing Market Overview
  • 26.2. South America Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Short-Read Sequencing Market

  • 27.1. Brazil Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Short-Read Sequencing Market

  • 28.1. Middle East Short-Read Sequencing Market Overview
  • 28.2. Middle East Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Short-Read Sequencing Market

  • 29.1. Africa Short-Read Sequencing Market Overview
  • 29.2. Africa Short-Read Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Short-Read Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Short-Read Sequencing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Short-Read Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Short-Read Sequencing Market Competitive Landscape
  • 30.2. Short-Read Sequencing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. GE HealthCare Technologies Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Cytiva Lifesciences
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Eurofins Scientific SE
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Short-Read Sequencing Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Beckman Coulter Inc.
  • 31.3. Illumina Inc.
  • 31.4. QIAGEN N.V.
  • 31.5. PerkinElmer Inc.
  • 31.6. BGI Genomics Co Ltd
  • 31.7. MGI Tech Co. Ltd.
  • 31.8. GenScript Biotech Corporation.
  • 31.9. 10x Genomics Inc.
  • 31.10. Novogene Co. Ltd
  • 31.11. Oxford Nanopore Technologies Ltd.
  • 31.12. Pacific Biosciences of California Inc.
  • 31.13. Macrogen Inc.
  • 31.14. Genewiz Inc.
  • 31.15. Zymo Research Corporation

32. Global Short-Read Sequencing Market Competitive Benchmarking

33. Global Short-Read Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Short-Read Sequencing Market

35. Short-Read Sequencing Market Future Outlook and Potential Analysis

  • 35.1 Short-Read Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Short-Read Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Short-Read Sequencing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer